Fundz

Epikast reported raising $5 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEFeb 28, 2023$5M of $10M raised

Amount Raised

$5 Million

$5 Million sold, per SEC Form D (first sale Feb 16, 2023)

Round Type

Venture

BrooklynHealth Care

Quick answer

Epikast raised $5 Million in a funding round, dated February 16, 2023. Epikast is based in Brooklyn, New York, United States.

How much did Epikast raise?
Epikast raised $5 Million in a funding round on February 16, 2023.
What does Epikast do?
Epikast is redefining how the biopharmaceutical industry engages with its most important stakeholders—patients, physicians, and other healthcare providers.
Where is Epikast based and how big is it?
Epikast is based in Brooklyn, New York, United States. Fundz records about 28 employees.
Who are the decision-makers at Epikast?
Fundz holds 2 contacts at Epikast. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Health Care around the same time

Companies in the same sectors as Epikast that raised within 45 days of this round, from Fundz verified event records.

  • Geneos Therapeutics raised $5M (Series A) on March 31, 2023.
  • Harvard Apparatus Regenerative Technology raised $6M on March 31, 2023.
  • aptihealth raised $11M on March 31, 2023.
  • Ablative Solutions raised $13M on March 31, 2023.
  • Bluedrop Medical raised $11M on March 31, 2023.
  • Dropstat raised $2.5M (Seed) on March 31, 2023.

Who to call at Epikast, and when

A new round usually means Epikast is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Epikast raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Epikast, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Epikast. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Epikast

Location

Brooklyn, New York, United States

About

Epikast is redefining how the biopharmaceutical industry engages with its most important stakeholders—patients, physicians, and other healthcare providers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Epikast raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Epikast's next move

See what Strategic adds

Epikast raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.